Biogen, Elan drug liver issues not new - US FDA - Guardian Unlimited
Published by Google Inc. February 27th, 2008 in Google FDA News, Regulatory Affairs
RTE.ie
Biogen, Elan drug liver issues not new - US FDA
Guardian Unlimited, UK -
… Elan Corp Plc's Tysabri drug was added to the label in January and is not a new issue, a US Food and Drug Administration spokeswoman said on Wednesday. …
Shares of Biogen and Elan fall on reports of liver damage in …
Drug stocks decline; Elan, Biogen slide on Tysabri woes
Biogen, Elan warn of liver injury risks w/Tysabri in letter posted …